Acerus Pharmaceuticals Co. (OTCMKTS:ASPCF) Short Interest Update

Acerus Pharmaceuticals Co. (OTCMKTS:ASPCF) was the recipient of a significant increase in short interest in the month of September. As of September 30th, there was short interest totalling 90,000 shares, an increase of 718.2% from the September 15th total of 11,000 shares. Based on an average daily volume of 17,200 shares, the days-to-cover ratio is presently 5.2 days.

Acerus Pharmaceuticals stock remained flat at $$0.03 during trading on Thursday. Acerus Pharmaceuticals has a 52 week low of $0.02 and a 52 week high of $0.08. The business’s 50 day moving average price is $0.03 and its 200 day moving average price is $0.04. The firm has a market cap of $42.59 million, a PE ratio of -0.92 and a beta of 1.01. The company has a debt-to-equity ratio of 2.08, a current ratio of 0.67 and a quick ratio of 0.45.

Acerus Pharmaceuticals Company Profile

Acerus Pharmaceuticals Corp. is a pharmaceutical company. The firm is focused on the commercialization and development of prescription products that improve patient experience, with a focus in the field of men’s health. It focuses on therapeutics for urology, andrology, and endocrinology. Its products include Estrace and Natesto.

Recommended Story: Purposes and Functions of the Federal Reserve

Receive News & Ratings for Acerus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acerus Pharmaceuticals and related companies with's FREE daily email newsletter.